These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9421451)

  • 1. The experience with neutron irradiation in locally advanced adenocarcinoma of the prostate.
    Forman JD; Porter AT
    Semin Urol Oncol; 1997 Nov; 15(4):239-43. PubMed ID: 9421451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved biochemical relapse-free survival with increased external radiation doses in patients with localized prostate cancer: the combined experience of nine institutions in patients treated in 1994 and 1995.
    Kupelian P; Kuban D; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):415-9. PubMed ID: 15667961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photon neutron mixed-beam radiotherapy of locally advanced prostate cancer.
    Haraf DJ; Rubin SJ; Sweeney P; Kuchnir FT; Sutton HG; Chodak GW; Weichselbaum RR
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):3-14. PubMed ID: 7642429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-year results of treatment for prostate cancer with low-dose rate temporary iridium-192 brachytherapy.
    Momma T; Saito S; Toya K; Yorozu A; Dokiya T; Murai M
    Int J Urol; 2006 Mar; 13(3):218-23. PubMed ID: 16643612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutron or photon irradiation for prostate tumors: enhancement of cytokine therapy in a metastatic tumor model.
    Hillman GG; Maughan RL; Grignon DJ; Yudelev M; Rubio J; Tekyi-Mensah S; Layer A; Che M; Forman JD
    Clin Cancer Res; 2001 Jan; 7(1):136-44. PubMed ID: 11205901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor control outcomes of patients treated with trimodality therapy for locally advanced prostate cancer.
    Copp H; Bissonette EA; Theodorescu D
    Urology; 2005 Jun; 65(6):1146-51. PubMed ID: 15922433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Year of treatment as independent predictor of relapse-free survival in patients with localized prostate cancer treated with definitive radiotherapy in the PSA era.
    Kupelian P; Thames H; Levy L; Horwitz E; Martinez A; Michalski J; Pisansky T; Sandler H; Shipley W; Zelefsky M; Zietman A; Kuban D
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):795-9. PubMed ID: 15925452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. External beam radiotherapy and hyperthermia in the treatment of patients with locally advanced prostate carcinoma.
    Algan O; Fosmire H; Hynynen K; Dalkin B; Cui H; Drach G; Stea B; Cassady JR
    Cancer; 2000 Jul; 89(2):399-403. PubMed ID: 10918172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast neutron therapy at the end of 1988--a survey of the clinical data.
    Wambersie A
    Strahlenther Onkol; 1990 Jan; 166(1):52-60. PubMed ID: 2405533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy.
    Cheung R; Tucker SL; Lee AK; de Crevoisier R; Dong L; Kamat A; Pisters L; Kuban D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):993-1002. PubMed ID: 15752878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Permanent interstitial brachytherapy in younger patients with clinically organ-confined prostate cancer.
    Merrick GS; Butler WM; Wallner KE; Galbreath RW; Adamovich E
    Urology; 2004 Oct; 64(4):754-9. PubMed ID: 15491715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Candidates for prostate radioactive seed implantation treated by external beam radiotherapy.
    Seung SK; Kroll S; Wilder RB; Posner MD; Roach M
    Cancer J Sci Am; 1998; 4(3):168-74. PubMed ID: 9612598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancer.
    Zelefsky MJ; Fuks Z; Hunt M; Lee HJ; Lombardi D; Ling CC; Reuter VE; Venkatraman ES; Leibel SA
    J Urol; 2001 Sep; 166(3):876-81. PubMed ID: 11490237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High dose rate and external beam radiotherapy in locally advanced prostate cancer.
    Viani GA; Pellizzon AC; GuimarĂ£es FS; Jacinto AA; dos Santos Novaes PE; Salvajoli JV
    Am J Clin Oncol; 2009 Apr; 32(2):187-90. PubMed ID: 19307949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk profiles to predict PSA relapse-free survival for patients undergoing permanent prostate brachytherapy.
    Potters L; Cha C; Oshinsky G; Venkatraman E; Zelefsky M; Leibel S
    Cancer J Sci Am; 1999; 5(5):301-6. PubMed ID: 10526671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen suppression plus radiation versus radiation alone for patients with stage D1/pathologic node-positive adenocarcinoma of the prostate: updated results based on national prospective randomized trial Radiation Therapy Oncology Group 85-31.
    Lawton CA; Winter K; Grignon D; Pilepich MV
    J Clin Oncol; 2005 Feb; 23(4):800-7. PubMed ID: 15681524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review of clinical results of fast neutron therapy in the USA.
    Peters LJ; Maor MH; Laramore GE; Griffin TW; Hendrickson FR
    Strahlentherapie; 1985 Dec; 161(12):731-8. PubMed ID: 4082208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage radiation for a rising PSA following radical prostatectomy.
    Maier J; Forman J; Tekyi-Mensah S; Bolton S; Patel R; Pontes JE
    Urol Oncol; 2004; 22(1):50-6. PubMed ID: 14969805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salvage permanent perineal radioactive-seed implantation for treating recurrence of localized prostate adenocarcinoma after external beam radiotherapy.
    Aaronson DS; Yamasaki I; Gottschalk A; Speight J; Hsu IC; Pickett B; Roach M; Shinohara K
    BJU Int; 2009 Sep; 104(5):600-4. PubMed ID: 19245439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retrospective analysis of results of p(65)+Be neutron therapy for treatment of prostate adenocarcinoma at the cyclotron of Louvain-la-Leuve. Part II: Side effects and their influence on quality of life measured with QLQ-C30 of EORTC.
    Scalliet PG; Remouchamps V; Curran D; Ledent G; Wambersie A; Richard F; van Cangh P
    Int J Radiat Oncol Biol Phys; 2004 Apr; 58(5):1549-61. PubMed ID: 15050336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.